You're in the driver's seat: our platform is tailored to the demands of different forensic expertises and developed to assist you. Latent print identification and bloodstain pattern analysis are currently supported.
Our annotation and automated analysis tools are designed ethically, responsibly, and with the expectations of the court in mind - whether they rely on AI or not.
Transitioning to our platform is quick and simple. Our users get signed up and started within minutes.
It only takes one click to present an image for court. Focus on the analysis, and let the platform do the rest. This single feature increased the productivity of our beta testers by up to 100%.
But it's not just about convenience. Our platform allows and promotes conventions and best practices such as the GYRO code and the ACE-V process.
Our toolkit for BPA is extensive and features varied measurement & annotation tools: from intuitive image scaling, to bloodstain ellipse annotations in a few clicks.
Next, have the app compute the origin of the bloodletting events for you. Whether it be the classic tangent method or more advanced 3D region of origin computation, we've got you covered.
At Clotho AI, we believe that the rigour and quality of forensic analyses can be further improved using mathematical reasoning and technology. Machine Learning in particular can play a pivotal role in this transformation provided that it is used appropriately and responsibly.
We are in a prime position to address this challenge and develop innovative scientific approaches. Our varied academic backgrounds and knowledge of the forensic field allow us to satisfy the practical needs of practitioners; the scientific rigour of researchers; and the legal requirements of the court.
In addition to the development of our existing products, we mentor research students as well as participate and lead research project proposals which can help fully bring this vision to life. Please free to contact us here to inquire about collaboration opportunities.
|BioTrack||Touch DNA||ANR, SNSF, SGDSN||7||1 723 197 €||Started in April 2022|